TXMD - セラピュ―ティクスMD (TherapeuticsMD Inc.)

TXMDのニュース

   Volatile Stock to Watch: TherapeuticsMD, Inc. (NASDAQ:TXMD), HEXO Corp. (NYSE:HEXO)  2021/06/16 22:37:00 Stock Equity
TherapeuticsMD, Inc. (TXMD) with the stream of -0.79% also noticed, India HEXO Corp. (HEXO) encountered a rapid change of -1.01% in the last hour of Wednesdays trading session. TherapeuticsMD, Inc. The post Volatile Stock to Watch: TherapeuticsMD, Inc. (NASDAQ:TXMD), HEXO Corp. (NYSE:HEXO) appeared first on Stocks Equity .
   TherapeuticsMD Submits Low Dose BIJUVA SNDA To FDA  2021/05/25 11:50:34 Business Insider Markets
(RTTNews) - TherapeuticsMD Inc. (TXMD) said Tuesday that it submitted a supplemental New Drug Application or "sNDA" for BIJUVA or estradiol and progesterone capsules, 0.5 mg/100 mg, to the U.S. Food and Drug Administration. The company expects to learn of the acceptance of the sNDA upon receipt of the Filing Review Notification from the FDA,
   TherapeuticsMD seeks FDA approval for low dose BIJUVA  2021/05/25 11:22:22 Seeking Alpha
   TherapeuticsMD Announces Submission of Low Dose BIJUVA 0.5 mg/100 mg Supplemental New Drug Application to FDA  2021/05/25 10:50:00 Wallstreet:Online
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, announced today that the Company submitted a supplemental New Drug Application (sNDA) for BIJUVA (estradiol and progesterone) capsules, 0.5 mg/100 mg, to the U.S. Food and Drug Administration (FDA). The Company expects to learn of the acceptance of the sNDA upon receipt of the Filing Review Notification
   TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA  2021/05/25 00:00:00 BioSpace
TherapeuticsMD, Inc., an innovative, leading womens healthcare company, announced that the Company submitted a supplemental New Drug Application for BIJUVA capsules, 0.5 mg/100 mg, to the U.S. Food and Drug Administration.
   TherapeuticsMD (NASDAQ:TXMD) vs. BELLUS Health (NASDAQ:BLU) Head to Head Survey  2021/03/09 09:24:44 Modern Readers
TherapeuticsMD (NASDAQ:TXMD) and BELLUS Health (NASDAQ:BLU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Profitability This table compares TherapeuticsMD and BELLUS Health’s net margins, return on equity and return on […]
   TherapeuticsMD (NASDAQ:TXMD) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS  2021/03/03 22:14:45 Transcript Daily
TherapeuticsMD (NASDAQ:TXMD) released its earnings results on Monday. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05), MarketWatch Earnings reports. TXMD remained flat at $$1.45 during midday trading on Wednesday. The company’s stock had a trading volume of 868,942 shares, compared to its average volume of 15,851,878. The […]
   Head-To-Head Review: Kiniksa Pharmaceuticals (NASDAQ:KNSA) & TherapeuticsMD (NASDAQ:TXMD)  2021/03/03 06:32:41 Modern Readers
TherapeuticsMD (NASDAQ:TXMD) and Kiniksa Pharmaceuticals (NASDAQ:KNSA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk TherapeuticsMD has a beta of 2.19, indicating that its share price is 119% […]
   Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?  2021/03/02 15:45:00 PR Newswire
NEW YORK, March 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JCS, TXMD, SSKN, INO, and INSG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results  2021/03/02 12:00:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD net product revenue in 2020 increased 84% over 2019; conference call at 8:30am ET today to discuss financial and business results for 2020.
   TherapeuticsMD (NASDAQ:TXMD) vs. BELLUS Health (NASDAQ:BLU) Head to Head Survey  2021/03/09 09:24:44 Modern Readers
TherapeuticsMD (NASDAQ:TXMD) and BELLUS Health (NASDAQ:BLU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Profitability This table compares TherapeuticsMD and BELLUS Health’s net margins, return on equity and return on […]
   TherapeuticsMD (NASDAQ:TXMD) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS  2021/03/03 22:14:45 Transcript Daily
TherapeuticsMD (NASDAQ:TXMD) released its earnings results on Monday. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05), MarketWatch Earnings reports. TXMD remained flat at $$1.45 during midday trading on Wednesday. The company’s stock had a trading volume of 868,942 shares, compared to its average volume of 15,851,878. The […]
   Head-To-Head Review: Kiniksa Pharmaceuticals (NASDAQ:KNSA) & TherapeuticsMD (NASDAQ:TXMD)  2021/03/03 06:32:41 Modern Readers
TherapeuticsMD (NASDAQ:TXMD) and Kiniksa Pharmaceuticals (NASDAQ:KNSA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk TherapeuticsMD has a beta of 2.19, indicating that its share price is 119% […]
   Thinking about buying stock in Communications Systems, TherapeuticsMD, STRATA Skin Sciences, Inovio Pharmaceuticals, or Inseego Corp?  2021/03/02 15:45:00 PR Newswire
NEW YORK, March 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JCS, TXMD, SSKN, INO, and INSG. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results  2021/03/02 12:00:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD net product revenue in 2020 increased 84% over 2019; conference call at 8:30am ET today to discuss financial and business results for 2020.

calendar